Area of research
Endocrinology, Diabetes and Metabolism · Genetics · sunil
Research interest
Research interests include Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes, and Diabetes Treatment and Management.
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.
Impact of Empagliflozin on Glomerular Hyperfiltration and Albuminuria in Youth with Type 2 Diabetes: Post Hoc Analysis of DINAMO.
Differential Contributions of IgM and IgG Autoantibodies to Serologic IA2 Reactivity in Type 1 Diabetes.
Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter].
Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. Reply to Mallone R, Bandini A [letter].
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes
The impact of fear of hypoglycaemia on sleep in adolescents with type 1 diabetes.
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results.
Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes.
Association between high levels of physical activity and improved glucose control on active days in youth with type 1 diabetes
Association between high levels of physical activity and improved glucose control on active days in youth with type 1 diabetes.
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Racial and Ethnic Disparities in Rates of Continuous Glucose Monitor Initiation and Continued Use in Children With Type 1 Diabetes.
Racial disparities in treatment and outcomes of children with type 1 diabetes.
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Early Racial/Ethnic Disparities in Continuous Glucose Monitor Use in Pediatric Type 1 Diabetes.
Human plasma-derived alpha<sub>1</sub> -proteinase inhibitor in patients with new-onset type 1 diabetes mellitus: A randomized, placebo-controlled proof-of-concept study.
A trend towards an early increase in ketoacidosis at presentation of paediatric type 1 diabetes during the coronavirus-2019 pandemic.
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes
Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes.
Insulin Pump Use in Children with Type 1 Diabetes: Over a Decade of Disparities.
Youth Involvement in the Decision to Start CGM Predicts Subsequent CGM Use.
Longitudinal trajectories of BMI z-score: an international comparison of 11,513 Australian, American and German/Austrian/Luxembourgian youth with type 1 diabetes.
Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study.
Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study.
Interaction between early environment and genetic predisposition instigates the metabolically obese, normal weight phenotype in children: findings from the BCAMS study.